Our company

What fuels our spirits every morning? We’re driven by a more sustainable future–a future where pressing environmental and social challenges are met with innovative, game-changing solutions. We’re driven by being on the brink of discovery, the chance to voyage into uncharted territory, grounded in our unwavering commitment to pioneering alternative solutions that can truly transform our world.

ABOUT US

About us

We are a world-leading synthetic biology platform with a core mission to harness nature to drive bio-based, low-impact solutions to address the most pressing planetary issues through innovation & exploration. Founded in 2018, based on foundational research conducted at the Centre of Excellence in Synthetic Biology at The University of Copenhagen and the Novo Nordisk Foundation Centre for Biosustainability at The Technical University of Denmark, and driven by a responsible future where these pressing issues are met with transformative solutions. Grounded in a robust scientific foundation and unrivalled expertise in cell factory engineering, precision fermentation and enzymatic enhancement, we proudly unveil world-leading synthetic biology platforms, poised to transform entire industries for the betterment of society and the planet. We’re inspired by nature to protect nature.

‍

Our Team

Our team, led by world-class scientists and inventors, is marked by diverse skills and expertise, as well as an unwavering commitment, forging a powerful team for driving change. This dynamic synergy fuels our pursuit of transformative advancements on our mission to reshape our world. With a proven history of successfully transitioning bio-based ingredients from the lab to commercialisation, our track record underscores our ability to turn innovative concepts into real-world solutions. This is our team pushing the boundaries of possibility.

‍

MANAGEMENT TEAM

Management Team
NETHAJI GALLAGE
CEO & CO-FOUNDER

Nethaji is a world-renowned biochemist with expertise in bioengineering cells to produce high-value molecules. She was previously a research leader at the University of Copenhagen where she led multidisciplinary industrial collaboration on bio-based vanillin production from research to commercialisation. She was awarded University of Copenhagen PhD-Brain prize in 2011 and Business Prize in 2018 for exceptional achievements in research commercialisation through spinouts and industry collaborations. Nethaji has worked with world-leading synthetic biology companies and has a track record of high impact publications and patents.

Nick_HeadShot
Management Team
NICK MILNE
CSO & CO-FOUNDER

Nick is a highly experienced metabolic engineer and fermentation scientist with a successful track record developing innovative bio-based manufacturing methods to replace unsustainable synthetic chemical processes with numerous high-impact scientific publications and patents. Since receiving a PhD from the Technical University of Delft in The Netherlands Nick has spent his career in both academia (The Novo Nordisk Foundation Center for Biosustainability) and industry (Evolva) engineering micro-organisms to efficiently and sustainably produce valuable products ranging from bio-fuels to bio-plastics, flavour ingredients, nutraceuticals and pharmaceuticals. With a broad knowledge of synthetic biology techniques, and a specialization in fermentation development, Nick has successfully taken projects all the way from initial proof-of-concept to commercial scale production.

Management Team
JAN K. VILLADSEN
CHIEF FINANCIAL OFFICER

Jan has been an executive finance professional for many years both as CFO in biotech companies – Gubra ApS. (privately held), NatImmune (Novo as controlling shareholder) and Neurokey (Novo as controlling shareholder) – and as Treasurer in a global company (Group 4 Falck A/S). In addition, he has held several senior positions in the financial sector primarily in investment banking and capital markets operations. He has two Graduate Diplomas in Business Administration from CBS. One in International Business and one in Organisation and Management.​

Management Team
Stephanie Michelle King
SVP Business Development

An experienced business development professional in the synbio industry, with 10+ years working in corporate and entrepreneurial environments. Her business development experience includes general management, marketing, sales, as well as business unit and innovation strategy. Her most recent position is VP of Business Development at London startup FabricNano, and prior to that she held a number of positions at Novozymes, including Head of Innovation for Future Fuels and Chemicals, and Business Portfolio Unit Lead for Water and Waste. Her industry experience, beyond synbio, includes biofuels and biochemicals, consumer health, water, carbon capture and utilization, and heterogeneous catalysis for production of ammonia, methanol, and syngas. Stephanie also holds a PhD in Environmental Chemistry from Harvard University and a Bachelors in Chemical Engineering from Rice University, giving her a strong analytical mindset for navigating the complexity of commercializing industrial biosolutions.

BOARD OF DIRECTORS

Directors
STEPHAN CHRISTGAU
Chairman of the board, Independent board member

A founding partner of the Nordic Life Science Venture fund, Eir Ventures. Prior to launching Eir Ventures, Stephan was part of setting up Novo Seeds, the early stage company creation and investment arm of Novo Holdings. During his 12 years at Novo Seeds, he led creation and funding of more than 25 companies in Europe, with a particular focus on Scandinavia.

Directors
Anna Søndergaard
Board member representing The Footprint Firm

Anna is an entrepreneur and investor with deep roots in the fashion industry. She co-founded Danish fashion brand Becksöndergaard Copenhagen, which was later sold to a private equity fund. Her expertise spans business development, sales, distribution, product and pricing strategy, and the professionalisation and scaling of start-ups. Over the past decade, she has served as a board member, advisor and investor in start-ups across sustainable fashion and apparel, the Internet of Things and lifestyle. Anna began her career in consulting at McKinsey & Company and as a Project Manager in advertising at Lowe Worldwide, and holds a Master of Science in International Marketing and Management from Copenhagen Business School.

Directors
Anna Zimmermann
Board observer representing Edaphon

Anna is a Senior Associate at Edaphon, an impact investment fund focused on biodiversity, ecosystem restoration and climate. She holds a PhD from KU Leuven and Ghent University, where her research sat at the intersection of microbiology and synthetic biology, and an MSc in Plant Biotechnology from Leibniz University Hannover. Her doctoral work focused on developing tools for evolutionary engineering in yeast using alternative CRISPR/Cas systems. At Edaphon, she supports investments that tackle ecosystem loss, biodiversity decline and climate change.

Directors
Nethaji Gallage
Board member representing Founders

Nethaji is a world-renowned plant biochemist and synthetic biologist passionate about developing nature-inspired and sustainable solutions for various industries such as pharmaceuticals, consumer goods, bulk manufacturing and energy. She has worked with world-leading synthetic biology companies and has a track record of high impact publications and patents. She was previously a research group leader at the Center for Synthetic Biology at the University of Copenhagen where she developed biosynthetic production platforms for natural and novel cannabinoids, and previously led multidisciplinary research project on biosynthetic vanillin production from the lab to commercialization.

Directors
ALEXANDRE OUIMET-STORRS
Representing the investors

Alex is a multicultural (Canada/France) engineer and experienced Venture Capitalist (traditional and corporate venture) with a demonstrated history of working in Cleantech (during the tough years from 2011-2016) and Deeptech with over 45 transactions under his belt. Skilled in Venture Capital, deal-making, developing early staged businesses into successful companies as well as performing exits and creating value for shareholders.

Directors
Akshat Kshetrapal
Board member representing DSM-Firmenich Ventures

Prior to joining DSM in 2020, Akshat sat on both sides of the table as an entrepreneur and investor. He started his entrepreneurial career by building WTEnergy, India's first carbon-trading platform and advisory services company, after which he embarked on his venture capital career at Sequoia Capital. Akshat has since gained extensive experience investing across the lifecycle of startups – with more than 45 investments totaling over 400 million euros and portfolio management for PGGM Private Equity, Max India, and Rockstart. At DSM, Akshat is responsible for investments in Europe and Israel in areas related to Nutrition, Health, and Biosciences. An Indian national currently living in Amsterdam, the Netherlands, Akshat holds an MBA from the Indian School of Business, and master’s degrees from the University of Amsterdam and the Delhi School of Economics.

Directors
Marianne Tochtermann
Independent board member

Marianne is a strategy and sustainability advisor and experienced board member with deep expertise in the fashion and furniture industries. She is Founder and Managing Director of Material ESG in Hamburg, Chair of the Supervisory Board of Bijou Brigitte, and sits on the boards of DK Company, Wheat and Dymak. She previously spent more than seven years at Carlsberg Group, most recently as Vice President Business Development and Controlling and Member of the Board, and later served as Managing Director of SCHWEIGERTOCHTERMANN for a decade. She began her career as a consultant at McKinsey & Company. Marianne holds an MSc in Public Administration and Public Policy from the London School of Economics and an MSc in Political Science from Aarhus University.

SCIENTIFIC ADVISORY BOARD

ADVISORY BOARD
PROF. JOANNA NEILL
Professor of Psychopharmacology, Manchester University
CLAIRE FOLDI, PhD
Research fellow, Monash University
PROF. BIRGER LINDBERG MØLLER
Professor of Plant Biochemistry, Copenhagen University
HENRIK KLITGAARD, PhD
CEO, Klitgaard Epilepsy Consulting